Yahoo appears to have "cleansed" this MB of spammers in both directions. Maybe it is the new Yahoo administration enforcing the TOS and tossing spammers . . . finally!
In double checking the Clinical Trials website (remember this is a site that allows sponsors to describe clinical trials but is verified by FDA), I found an important piece of information. Bayer (the German giant of a biopharma) has a Cipro dry powder antibiotic recruiting for a Phase III study. Aradigm's is "not yet recruiting." However, looking at the protocols Bayer's dry powder is BID (twice per day) and Aradigm's is SID (once per day). This difference seems to be trivial for some, but not if you are the person who has to remember and schedule BID treatments. This is the same "breakthrough" feature for Arikace in INSM's presentations. This is going to be a decisive factor in terms of fulfilling treatment protocols, cost and achieving a therapeutic effect. I am anxious for this protocol to become labeled as "Recruiting." Also Bayer has to accrue 300 patients and ARDM only 255 according to the clinical trial outlines.